Skip to main content

Peer Review reports

From: Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients

Original Submission
5 Feb 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
20 Mar 2023 Reviewed Reviewer Report
27 Mar 2023 Reviewed Reviewer Report
28 Mar 2023 Reviewed Reviewer Report
8 Apr 2023 Author responded Author comments - Yue Yu
Resubmission - Version 4
8 Apr 2023 Submitted Manuscript version 4
13 Apr 2023 Author responded Author comments - Yue Yu
Resubmission - Version 5
13 Apr 2023 Submitted Manuscript version 5
17 Apr 2023 Author responded Author comments - Yue Yu
Resubmission - Version 6
17 Apr 2023 Submitted Manuscript version 6
18 Apr 2023 Author responded Author comments - Yue Yu
Resubmission - Version 7
18 Apr 2023 Submitted Manuscript version 7
24 Apr 2023 Author responded Author comments - Yue Yu
Resubmission - Version 8
24 Apr 2023 Submitted Manuscript version 8
28 Jun 2023 Reviewed Reviewer Report
4 Jul 2023 Reviewed Reviewer Report
21 Jul 2023 Reviewed Reviewer Report
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
3 Aug 2023 Editorially accepted
23 Sep 2023 Article published 10.1186/s12885-023-11249-8

You can find further information about peer review here.

Back to article page